top of page
matthew-guay-Q7wDdmgCBFg-unsplash.jpg
bg-dégradé.png

Actualités

LSL Pharma Group announces its fiscal Q3-24 results

25 nov. 2024

LSL Pharma Group announces its fiscal Q3-24 results

LSL PHARMA GROUP ANNOUNCES STRONG FISCAL Q3-24 RESULTS AND $2.4 MILLION DEBT FINANCINGS TO SUPPORT ITS GROWTH INITIATIVES

ACTUALITÉS ANTÉRIEURES

25 nov. 2024

LSL Pharma Group announces its fiscal Q3-24 results

25 nov. 2024

Groupe LSL Pharma annonce ses résultats financiers du Q3-24

6 nov. 2024

New International clients and Production Capacity increase for Steri-Med

bottom of page